drugset / Trial / NCT00892281
ORCA - Oracea® for Rosacea: A Community-based Assessment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to assess the effectiveness, safety, subject satisfaction and quality of life with Oracea® when used as monotherapy or as add-on therapy to existing topical regimens for the treatment of rosacea.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 40 mg | — |